BFA
OCAT

BlackRock Fund Advisors’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

BlackRock Fund Advisors’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,174,333
Closed -$9.89M – 4370
2015
Q4 		$9.89M Buy
1,174,333
+99,588
+9% +$666K ﹤0.01% 2454
2015
Q3 		$4.49M Buy
1,074,745
+132,089
+14% +$577K ﹤0.01% 2858
2015
Q2 		$4.97M Buy
+942,656
New +$6.04M ﹤0.01% 2926

BlackRock Fund Advisors's OCAT Position: Q1 2016 in Review

BlackRock Fund Advisors sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 1,174,333 shares — an estimated $9.89M sold.

BlackRock Fund Advisors first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $9.89M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • BlackRock Fund Advisors reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • BlackRock Fund Advisors sold 1,174,333 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $9.89M.
  • BlackRock Fund Advisors first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • BlackRock Fund Advisors's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $9.89M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on BlackRock Fund Advisors's 13F filing for Q1 2016, filed 10 May 2016.